HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY: ifrs:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
| Value | {"amount": 150000000.0} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T22:45:21.755947+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/621f98e6-a2f6-412c-b515-3f590cf7d0f6
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:549300BNS685UXH4JI75:2025-12-31Retrieved: 2026-08-23T22:45:21.755947+02:00
Raw response sha256:
c9b90e219264876c07ff9e67a0a5f951…Cite as: FACTANKER, https://factanker.com/fact/621f98e6-a2f6-412c-b515-3f590cf7d0f6
History
- no predecessors — first report